Public health has moved from a technocratic discipline into a politically charged arena where practitioners must navigate a deeply polarized social landscape. The Boston University School of Public Health (BUSPH) has spent the last half-century evolving from a localized initiative into a global
The immunotherapy revolution is fundamentally reshaping the treatment landscape for liver cancer by displacing older, single-agent systemic therapies with advanced combinations. As the global healthcare sector enters a period of unprecedented investment, the financial trajectory for liver cancer
The paradox of modern immunization is that the very success of vaccines has made the dangerous diseases they prevent feel like distant, non-threatening historical events. In today’s healthcare landscape, doctors often find themselves battling ghosts of the past that the public no longer fears,
Selective protection represents a major breakthrough in oncology, potentially allowing physicians to prescribe higher radiation doses to kill cancer cells with fewer side effects. For decades, the primary constraint in radiotherapy has not been the ability to destroy a tumor, but rather the
In regions like Nepal and Vietnam, digital health applications and wearable devices are being used to bypass the social stigma surrounding sexual and gender minority health. This innovative approach is a cornerstone of the work conducted at the Shrestha Lab at the University of Connecticut, where
Emergency preparedness experts emphasize the need for medical countermeasures that can be easily distributed to civilian populations following a nuclear accident. This clinical necessity drove researchers at the Fralin Biomedical Research Institute at VTC to develop XOlacta, an experimental oral
